Uncategorized
Bruker Introduces MALDI Tissuetyper™ Solution with New High Speed rapifleX™ MALDI-TOF MS System for Anatomical Pathology Research
ST. LOUIS--(BUSINESS WIRE)--At the 63rd ASMS Conference on Mass Spectrometry & Allied Topics (ASMS), Bruker (NASDAQ: BRKR) announced the launch of the novel MALDI Tissuetyper solution, based on the new rapifleX MALDI-TOF Mass Spectrometry system. The introduction of the revolutionary rapifleX as the new instrument platform for MALDI imaging anatomical pathology research further enhances Bruker’s leadership position for MALDI-TOF-based applications solutions. The new rapifleX system eliminat
